EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells

Seblewongel Asrat, Joseph C Devlin, Andrea Vecchione, Brian Klotz, Ian Setliff, Devin Srivastava, Andre Limnander, Ashique Rafique, Christina Adler, Stephen Porter, Andrew J Murphy, Gurinder S Atwal und 3 weitere

Cell Reports Methods · 2023

DOI: 10.1016/j.crmeth.2023.100522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports Methods, 2023. Verfasst von Seblewongel Asrat und 14 weiteren Autor:innen. Beteiligte Einrichtung: Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA. Hauptthemen laut MEDLINE: Antibody-Producing Cells, Antigens. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Regeneron Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following activation by cognate antigen, B cells undergo fine-tuning of their antigen receptors and may ultimately differentiate into antibody-secreting cells (ASCs). While antigen-specific B cells that express surface receptors (B cell receptors [BCRs]) can be readily cloned and sequenced following flow sorting, antigen-specific ASCs that lack surface BCRs cannot be easily profiled. Here, we report an approach, TRAPnSeq (antigen specificity mapping through immunoglobulin [Ig] secretion TRAP and Sequencing), that allows capture of secreted antibodies on the surface of ASCs, which in turn enables high-throughput screening of single ASCs against large antigen panels. This approach incorporates flow cytometry, standard microfluidic platforms, and DNA-barcoding technologies to characterize antigen-specific ASCs through single-cell V(D)J, RNA, and antigen barcode sequencing. We show the utility of TRAPnSeq by profiling antigen-specific IgG and IgE ASCs from both mice and humans and highlight its capacity to accelerate therapeutic antibody discovery from ASCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibody-Producing CellsAntigensHumansAnimalsMiceB-LymphocytesAntibodiesReceptors, Antigen, B-Cell

Stichwörter der Autor:innen

IgEIgGantibody-secreting cellsplasma cellsplasmablastsrepertoire analysissecretion trap

Substanzen

AntigensAntibodiesReceptors, Antigen, B-Cell

Autor:innen und Institutionen

  • Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.

Förderung

  • Regeneron Pharmaceuticals

Zitieren

APA

Asrat, S., Devlin, J. C., Vecchione, A., Klotz, B., Setliff, I., Srivastava, D., Limnander, A., Rafique, A., Adler, C., Porter, S., Murphy, A. J., Atwal, G. S., Sleeman, M. A., Lim, W. K., & Orengo, J. M. (2023). TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells. Cell Reports Methods. https://doi.org/10.1016/j.crmeth.2023.100522

Vancouver

Asrat S, Devlin JC, Vecchione A, Klotz B, Setliff I, Srivastava D, et al. TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells. Cell Reports Methods. 2023. doi:10.1016/j.crmeth.2023.100522

BibTeX
@article{Asrat2023,
  author = {Asrat, Seblewongel and Devlin, Joseph C and Vecchione, Andrea and Klotz, Brian and Setliff, Ian and Srivastava, Devin and Limnander, Andre and Rafique, Ashique and Adler, Christina and Porter, Stephen and Murphy, Andrew J and Atwal, Gurinder S and Sleeman, Matthew A and Lim, Wei Keat and Orengo, Jamie M},
  title = {TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells},
  journal = {Cell Reports Methods},
  year = {2023},
  doi = {10.1016/j.crmeth.2023.100522}
}
Kostenlos starten →